Drug Discovery Today (2021) 26(8):19912002
Going on a GLP-1 is a lot like going on a statin, Hayes explains
Does the Precision Peptide Genetic Test say which program will work
Even before it added compounded GLP-1s to its portfolio, Hims & Hers said in its fourth-quarter earnings report that it expects its weight loss program to bring in more than $100 million in revenue by the end of 2025
In the end, if we can increase access to these tools while maintaining oversight, and put patient outcomes over profits, that is what will ultimately move the needle on the proverbial scale in the pandemic of excess weight. And Cheng noted that: It is better to use FDA approved treatments rather than experimental and unproven treatments. Moreover, it is important to speak with your healthcare professional regarding the use of GLP-1 or microdosing, he emphasized
In addition, a significant improvement in the first and second phase of insulin secretion was observed with tirzepatide treatment, as well as an improvement in beta cell function, estimated with beta-cell glucose sensitivity